GenesisCare Grand Rounds: Modern radiotherapy to treat widespread non-melanoma skin cancer

GenesisCare Grand Rounds: Modern radiotherapy to treat widespread non-melanoma skin cancer

Radiation therapy has been used effectively to treat non-melanoma skin cancer (NSMC) for nearly a century. Considerable progress in such care has been facilitated by technological advancements, such as widefield radiation, including volumetric modulated arc therapy (VMAT). VMAT has emerged as a promising treatment for patients with widespread NMCS and surrounding pre-cancerous lesions, and have exhausted other options.

GenesisCare has been at the forefront of research investigating the efficacy and safety of widefield radiation therapy for patients with NMSC. In this recorded Grand Rounds, originally presented in June 2022, our physicians present 12-month outcomes from patients prospectively enrolled into the National (Australian) Dermatology Radiation Oncology Registry (NDROR), who were prescribed widefield VMAT for increasingly unmanageable presentations of non-melanomatous skin (keratinocyte) cancer. These findings were recently published in the Journal of Dermatological Treatment.

GenesisCare Grand Rounds
/content/dam/asset-migration/other/Grand_Rounds.png

Moderator

Wally Curran

Global CMO

Meet the panel

Andrew Potter, MBBS, BMedSc(Hons), FRANZCR

Radiation Oncologist
South Australia, AU

Thomas Boike, MD

GenesisCare-Affiliated Radiation Oncologist, Michigan USA
Co-Chair of the Eastern Clinical Management Committee, USA

David Esteban, MD

Radiation Oncologist
Toledo, Spain

Lynda Spelman, MBBS, FACD

Guest | Dermatologist
Queensland, AU